Avidity Biosciences Inc’s recent filing unveils that its Director Thompson Tamar unloaded Company’s shares for reported $1.35 million on Oct 07 ’24. In the deal valued at $44.98 per share,30,000 shares were sold. As a result of this transaction, Thompson Tamar now holds 0 shares worth roughly $0.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Thompson Tamar bought 30,000 shares, generating $1,419,000 in total proceeds.
Before that, Flanagan W. Michael sold 62,500 shares. Avidity Biosciences Inc shares valued at $2,976,112 were divested by the CSTO at a price of $47.62 per share. As a result of the transaction, Flanagan W. Michael now holds 85,389 shares, worth roughly $3.99 million.
Goldman initiated its Avidity Biosciences Inc [RNA] rating to a Buy in a research note published on September 24, 2024; the price target was $59. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in late August with a ‘”an Overweight”‘ rating. BofA Securities began covering RNA with “Buy” recommendation on May 03, 2024. Cantor Fitzgerald started covering the stock on March 14, 2024. It rated RNA as “an Overweight”.
Price Performance Review of RNA
On Tuesday, Avidity Biosciences Inc [NASDAQ:RNA] saw its stock fall -0.02% to $46.70. Over the last five days, the stock has gained 0.80%. Avidity Biosciences Inc shares have risen nearly 416.02% since the year began. Nevertheless, the stocks have risen 655.66% over the past one year. While a 52-week high of $49.41 was reached on 10/02/24, a 52-week low of $4.82 was recorded on 01/02/24. SMA at 50 days reached $43.96, while 200 days put it at $30.30.
Levels Of Support And Resistance For RNA Stock
The 24-hour chart illustrates a support level at 45.53, which if violated will result in even more drops to 44.35. On the upside, there is a resistance level at 47.55. A further resistance level may holdings at 48.39. The Relative Strength Index (RSI) on the 14-day chart is 55.28, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.91, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 32.26%. Stochastics %K at 67.38% indicates the stock is a holding.
How much short interest is there in Avidity Biosciences Inc?
A steep rise in short interest was recorded in Avidity Biosciences Inc stocks on 2024-09-30, growing by 3.97 million shares to a total of 14.77 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 10.81 million shares. There was a rise of 26.84%, which implies that there is a positive sentiment for the stock.
